IECM
MED icon

Intrinsic Edge Capital Management’s Medifast MED Stock Holding History

Intrinsic Edge Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-50,000
Closed -$6.42M – 170
2019
Q2 		$6.42M Buy
+50,000
New +$6.95M 0.76% 50
2018
Q3 		– Sell
-189
Closed -$613K – 171
2018
Q2 		$613K Buy
+189
New +$24.2K 0.07% 137

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Intrinsic Edge Capital Management's MED Position: Q1 2020 in Review

Intrinsic Edge Capital Management sold out of Medifast (MED) in Q1 2020, closing a stake of 115,549 shares — an estimated $12.7M sold.

Intrinsic Edge Capital Management first reported a position in MED in Q2 2018 and held it in 7 quarters. The position peaked at $12.8M in Q3 2019. 202 funds tracked by Wall St. Rank hold MED as of Q1 2020.

  • Intrinsic Edge Capital Management reported no remaining Medifast position as of Q1 2020 after selling out during the quarter.
  • Intrinsic Edge Capital Management sold 115,549 Medifast shares in Q1 2020, an estimated $12.7M.
  • Intrinsic Edge Capital Management first reported a position in Medifast in Q2 2018 and held it in 7 quarters.
  • Intrinsic Edge Capital Management's Medifast position peaked at $12.8M in Q3 2019.
  • 202 funds tracked by Wall St. Rank held Medifast as of Q1 2020.

Based on Intrinsic Edge Capital Management's 13F filing for Q1 2020, filed 15 May 2020.